MESO Mesoblast
- 20.092
- -0.948-4.50%
Mesoblast News
Mesoblast Stock Rockets to New 52-Week High
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday
Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads
Mesoblast Shareholder Offers 2M Ordinary Shares Represented By 200K ADSs On Nasdaq Under Symbol "MESO" And Australian Exchange As "MSB"; Company To Receive $9.06 Per ADS Upon Warrant Exercise, No Proceeds From ADS Sales
Mesoblast Sees Major Change in Substantial Holding
What Awaits These 4 Biotech Stocks That More Than Doubled in 2024
ASX: Riding the Scariest Rollercoaster on the Sharemarket
This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Jefferies Downgrades Mesoblast to Hold From Buy; Price Target Is AU$2.30
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15
US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
ISCT Hails Landmark US FDA Approval of RYONCIL as Major Milestone for MSC Field
Mesoblast Director Increases Stake With Major Share Acquisition
Mesoblast Limited Expands Equity With New Share Quotation
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Mesoblast MESO Approval; Sangamo SGMO Astellas Pharma ALPMY Licensing Deal
What's Going On With Mesoblast Shares Thursday?
No Data
